Fortis Healthcare Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Fortis Healthcare Ltd is ₹ 720 as of 23 Oct 15:30 . The P/E Ratio of Fortis Healthcare Ltd changed from 39.5 on March 2022 to 57.6 on March 2026 . This represents a CAGR of 7.84% over 5 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Fortis Healthcare Ltd changed from ₹ 15023 crore on March 2021 to ₹ 59988 crore on March 2026 . This represents a CAGR of 25.96% over 6 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Fortis Healthcare Ltd for the Jun '26 is ₹ 2573 crore as compare to the Mar '26 revenue of ₹ 2375 crore. This represent the growth of 8.34% The revenue of Vimta Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Fortis Healthcare Ltd for the Jun '26 is ₹ 565.5 crore as compare to the Mar '26 ebitda of ₹ 530.45 crore. This represent the growth of 6.61% The ebitda of Vimta Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Fortis Healthcare Ltd changed from ₹ 173.98 crore to ₹ 272.8 crore over 9 quarters. This represents a CAGR of 22.13% The net profit of Vimta Labs Ltd changed from ₹ 12.28 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Fortis Healthcare Ltd changed from 78.45 % on March 2023 to 32.78 % on March 2026 . This represents a CAGR of -19.60% over 4 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Fortis Healthcare Ltd

Fortis Healthcare Limited (FHL) is one of the largest healthcare services providers in India with 27 hospitals, ~4,750+ operational beds and 400+ diagnostics centres as of 31 March, 2025.
The Company offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services to patients in areas such as Cardiac Care, Orthopedics, Neurosciences, Oncology, renal care, Gastroenterology and Mother and Child care..
They are delivering quality healthcare services to patients in modern facilities using advanced technology. SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Fortis Healthcare Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Fortis Healthcare Ltd or Vimta Labs Ltd?

Market cap of Fortis Healthcare Ltd is 54,356 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Fortis Healthcare Ltd and Vimta Labs Ltd?

The stock performance of Fortis Healthcare Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Healthcare Ltd and Vimta Labs Ltd?

As of October 24, 2026, the Fortis Healthcare Ltd stock price is INR ₹720.0. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Fortis Healthcare Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Fortis Healthcare Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.